Brief: Hepion Pharmaceuticals Receives $3.2 Million In Aggregate Non-Dilutive Funding
09/01/2023 13:27
Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS RECEIVES $3.2 MILLION IN AGGREGATE
NON-DILUTIVE FUNDING
Source text for Eikon: ID:nGNX1YwQmk
Further company coverage: HEPA.O
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement